GO:0008198 ferrous iron binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008198 ferrous iron binding is a molecular function defined as binding to a ferrous iron ion, Fe(II), and is distinct from binding to ferric iron, Fe(III).
• Ferrous iron binding is central to intestinal iron absorption, cellular iron transport, iron storage, and iron-dependent enzyme catalysis.
• Key proteins that bind Fe(II) include DMT1, ferritin, FpvC, and lactoferrin, each with distinct structural and functional roles.
• Dysregulated ferrous iron binding contributes to iron-deficiency anemia, iron overload, ferroptosis, and neurodegeneration.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of Fe(II)-binding proteins in disease and metabolism.
• Methods such as isothermal titration calorimetry, Mössbauer spectroscopy, X-ray crystallography, and ferroptosis assays are used to study Fe(II) binding.
Description
Ferrous iron binding, formally annotated as GO:0008198, is a molecular function describing the selective interaction of a protein or biomolecule with the reduced form of iron, Fe(II). This function is essential for organisms to acquire, transport, store, and utilize iron, an element required for oxygen transport, DNA synthesis, and mitochondrial respiration. Because Fe(II) is highly reactive and can promote oxidative damage, its binding is tightly controlled by specialized proteins. Understanding ferrous iron binding is therefore fundamental to iron biology, nutrition, and disease research. At the cellular level, ferrous iron binding enables iron uptake across the intestinal brush border, release from endosomes, storage within ferritin, and incorporation into heme and iron-sulfur clusters. Proteins such as DMT1 mediate Fe(II) transport, while ferritin binds and oxidizes Fe(II) for safe storage. In bacteria, dedicated ferrous iron-binding proteins such as FpvC support siderophore-mediated iron acquisition. These diverse examples illustrate that GO:0008198 is not a single pathway but a recurring biochemical function deployed across kingdoms. For researchers, GO:0008198 provides a precise annotation to interpret genomic, proteomic, and functional data. It helps distinguish Fe(II)-dependent mechanisms from Fe(III)-binding or heme-binding processes, and it guides experimental design in iron-deficiency anemia, iron overload, ferroptosis, and infection. This article summarizes the definition, mechanisms, key genes, disease links, and CRISPR-based research strategies for ferrous iron binding.
ferrous iron binding At A Glance
| GO ID | GO:0008198 |
|---|---|
| GO term | ferrous iron binding |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to a ferrous iron ion, Fe(II). |
| Major function | Selective coordination of Fe(II) for transport, storage, and catalysis |
| Representative proteins | DMT1, ferritin, FpvC, lactoferrin |
| Related diseases | Iron-deficiency anemia, iron overload, ferroptosis, neurodegeneration |
| Research methods | ITC, Mössbauer spectroscopy, crystallography, ferroptosis assays, CRISPR models |
What Is GO:0008198?
GO:0008198 ferrous iron binding is defined by the Gene Ontology as the binding to a ferrous iron ion, Fe(II). In practical terms, it describes any molecular interaction in which a protein or other biomolecule selectively coordinates the reduced ferrous form of iron, rather than the oxidized ferric form, Fe(III). This function is annotated at the molecular_function level and is often associated with iron transport, storage, and enzyme catalysis.
Why Is ferrous iron binding Important in Cell Biology?
Ferrous iron binding is important because Fe(II) is both essential and potentially toxic, and its controlled binding determines how cells acquire, distribute, and store iron. Defects in Fe(II) binding or transport underlie common human disorders, including iron-deficiency anemia and iron overload, and contribute to ferroptosis in neurons and other tissues. Moreover, Fe(II)-binding proteins are drug targets and nutritional intervention points, making GO:0008198 a high-value annotation for biomedical research.
• Enables intestinal absorption of dietary iron through DMT1 and related transporters.
• Supports safe iron storage by ferritin, which binds and oxidizes Fe(II).
• Facilitates bacterial iron acquisition via proteins such as FpvC.
• Is linked to iron-deficiency anemia, a major global health problem.
• Contributes to iron overload and ferroptosis in neural and other tissues.
• Provides a target for lactoferrin and other iron-binding therapeutics.
• Helps interpret genome-wide association and functional genomics data.
• Guides CRISPR model design for causal testing of iron-related genes.
• Informs nutrition and supplementation strategies in children and IBD patients.
• Connects iron metabolism to oxidative stress and cell death pathways.
Molecular Mechanism of ferrous iron binding
Selective recognition of Fe(II)
In simple terms: Proteins that bind ferrous iron have pockets that fit Fe(II) specifically, like a lock for a key.
Ferrous iron binding proteins discriminate Fe(II) from Fe(III) and other divalent metals through coordination geometry, ligand identity, and redox state. For example, the bacterial protein FpvC uses a unique ferrous iron binding mode associated with large conformational changes, ensuring selectivity for Fe(II). In ferritin from a pennate diatom, the mechanism of ferrous iron binding and oxidation has been resolved, showing how Fe(II) is captured before being oxidized. These studies demonstrate that GO:0008198 reflects a precise biochemical recognition event rather than nonspecific metal association.
Transport and uptake
In simple terms: Some proteins act as doors that let ferrous iron into cells or move it between compartments.
DMT1 is a major transporter that mediates Fe(II) uptake across the intestinal brush border and endosomal membranes. Intestinal iron absorption depends on the coordinated action of DMT1 and other proteins that bind and transfer Fe(II). Conrad and colleagues provided an early update on iron absorption and transport, establishing the framework for understanding Fe(II) movement in the body. Yanatori and Kishi later reviewed DMT1 and iron transport, highlighting its role in systemic iron homeostasis. Thus, ferrous iron binding is a prerequisite for directional iron transport.
Storage and oxidation
In simple terms: Ferritin traps ferrous iron and converts it into a safe storage form.
Ferritin binds Fe(II) and catalyzes its oxidation to Fe(III), which is then stored in a mineral core. This process prevents Fe(II) from participating in Fenton chemistry and generating harmful radicals. The diatom ferritin study by Pfaffen et al. elucidated the mechanism of ferrous iron binding and oxidation, providing a structural and kinetic basis for this function. Therefore, GO:0008198 is integral to iron storage and detoxification.
Enzyme catalysis and cofactor assembly
In simple terms: Many enzymes need ferrous iron in their active site to work.
Fe(II) is a cofactor for enzymes involved in DNA synthesis, oxygen sensing, and mitochondrial metabolism. Although specific enzymes vary, the common theme is that Fe(II) must be bound before catalysis can occur. This dependence links ferrous iron binding to broad cellular processes and explains why disruptions cause pleiotropic phenotypes.
Regulation by iron status
In simple terms: Cells adjust how much ferrous iron they bind based on how much iron is available.
Iron absorption and transport are regulated by systemic iron status, including hepcidin and iron regulatory proteins. Fuqua et al. reviewed intestinal iron absorption, emphasizing that uptake is adjusted to body needs. In perinatal hypoxia, cold-inducible RNA binding protein alleviates iron overload-induced neural ferroptosis, indicating that Fe(II) binding and handling are responsive to stress. These regulatory layers ensure that ferrous iron binding is matched to metabolic demand.
Key Genes Involved in GO:0008198 ferrous iron binding
The following genes and proteins represent major Fe(II)-binding or Fe(II)-transport functions relevant to GO:0008198.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DMT1 (SLC11A2) | Ferrous iron transporter | Intestinal absorption and endosomal iron release |
| Ferritin (FTL/FTN) | Binds and oxidizes Fe(II) for storage | Iron storage and detoxification |
| FpvC | Bacterial ferrous iron binding protein | Siderophore-mediated iron acquisition |
| Lactoferrin (LTF) | Iron-binding glycoprotein | Therapeutic iron chelation and anemia |
| Hepcidin (HAMP) | Regulates iron absorption | Systemic iron homeostasis |
| Ferroportin (SLC40A1) | Exports iron from cells | Iron efflux and overload |
| Transferrin (TF) | Binds ferric iron in circulation | Iron delivery to tissues |
| Transferrin receptor (TFRC) | Mediates iron uptake | Cellular iron acquisition |
| IRP1 (ACO1) | Iron regulatory protein | Post-transcriptional regulation |
| IRP2 (IREB2) | Iron regulatory protein | Iron sensing and regulation |
| CIRBP | Cold-inducible RNA binding protein | Neural ferroptosis under hypoxia |
| NCOA4 | Ferritinophagy receptor | Ferritin degradation and iron release |
| STEAP3 | Ferrireductase | Reduces Fe(III) to Fe(II) for transport |
| Dcytb (CYBRD1) | Ferrireductase | Intestinal Fe(III) reduction |
| HMOX1 | Heme oxygenase | Releases Fe(II) from heme |
| FTH1 | Ferritin heavy chain | Ferroxidase activity |
| FTL | Ferritin light chain | Iron core formation |
How Is ferrous iron binding Regulated?
Ferrous iron binding is regulated at multiple levels. Systemically, hepcidin controls iron absorption and release, thereby influencing the availability of Fe(II) for binding proteins. At the cellular level, iron regulatory proteins (IRP1 and IRP2) modulate the translation and stability of mRNAs encoding iron transporters and storage proteins. Intestinal iron absorption is adjusted to body iron needs, as reviewed by Fuqua et al.. Under stress conditions such as perinatal hypoxia, cold-inducible RNA binding protein alleviates iron overload-induced neural ferroptosis, indicating stress-responsive regulation of Fe(II) handling. These mechanisms ensure that ferrous iron binding is dynamically matched to physiological demand.
ferrous iron binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DMT1 (SLC11A2) | Iron-deficiency anemia | Intestinal organoids with DMT1 knockout |
| Ferritin (FTL/FTN) | Iron overload, ferroptosis | Ferritin knockout cells with Fe(II) challenge |
| Lactoferrin (LTF) | Anemia in IBD | Lactoferrin overexpression in intestinal cells |
| CIRBP | Neural ferroptosis | CIRBP knockout neurons under hypoxia |
| FpvC | Bacterial infection | FpvC mutant Pseudomonas aeruginosa |
Iron-deficiency anemia
Iron-deficiency anemia results from insufficient iron for hemoglobin synthesis and is a major global health issue. Clinical trials have compared low-dose ferrous sulfate with iron polysaccharide complex in young children, showing the importance of Fe(II) supplementation strategies. Lactoferrin, an iron-binding glycoprotein, has also been tested for iron-deficiency anemia in children with inflammatory bowel disease. These studies highlight that ferrous iron binding and delivery are central to anemia treatment.
Iron overload and ferroptosis
Excessive Fe(II) can trigger ferroptosis, a form of regulated cell death driven by lipid peroxidation. In perinatal hypoxia, iron overload-induced neural ferroptosis is alleviated by cold-inducible RNA binding protein, linking Fe(II) handling to neuroprotection. Ferritin, which binds and oxidizes Fe(II), is a key defense against iron-mediated toxicity. Thus, dysregulated ferrous iron binding contributes to oxidative tissue damage.
Infection and bacterial iron acquisition
Bacterial pathogens use ferrous iron binding proteins such as FpvC to acquire iron from the host. This function is essential for Pseudomonas aeruginosa virulence and represents a potential antimicrobial target. Understanding GO:0008198 in bacteria may inform new therapies against iron-dependent infections.
From ferrous iron binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DMT1 impair intestinal iron uptake? | DMT1 knockout intestinal epithelial cells or organoids |
| Does a point mutation in ferritin alter Fe(II) oxidation? | Ferritin point-mutation knock-in cells |
| Can lactoferrin overexpression rescue anemia? | Lactoferrin overexpression in intestinal or hepatic cells |
| Does CIRBP protect against ferroptosis? | CIRBP knockout neurons with iron overload |
| How does FpvC bind Fe(II)? | FpvC mutant bacteria and purified protein |
| Does hepcidin regulation affect Fe(II) transport? | Hepcidin knockout or overexpression models |
How to Study the ferrous iron binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isothermal titration calorimetry | Binding affinity and stoichiometry | Fe(II) binding to purified proteins |
| Mössbauer spectroscopy | Iron oxidation state and coordination | Ferritin Fe(II) oxidation |
| X-ray crystallography | Three-dimensional structure of Fe(II) binding site | FpvC conformational changes |
| Ferroptosis assay | Cell death and lipid peroxidation | Neural iron overload |
| RNA-seq | Transcriptional changes | Iron-responsive gene expression |
| Proteomics | Protein abundance and interactions | Iron metabolism networks |
| CRISPR knockout | Loss-of-function phenotypes | DMT1 function in iron transport |
| Clinical trial | Efficacy of iron supplementation | Iron-deficiency anemia |
Biophysical binding assays
Isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR) can measure the affinity and stoichiometry of Fe(II) binding to purified proteins. These methods are essential to confirm that a candidate protein directly binds Fe(II) as annotated by GO:0008198.
Spectroscopic and structural methods
Mössbauer spectroscopy and X-ray crystallography provide direct evidence of Fe(II) coordination and conformational changes. The FpvC study used structural analysis to reveal a unique ferrous iron binding mode. Ferritin studies used kinetic and spectroscopic approaches to resolve Fe(II) binding and oxidation.
Cell-based iron and ferroptosis assays
Ferroptosis assays, lipid peroxidation measurements, and iron-sensitive fluorescent probes can assess the functional consequences of Fe(II) binding in cells. These assays are particularly useful in neurons and other cells exposed to iron overload.
Genetic and genomic approaches
CRISPR knockout, point-mutation, and overexpression models allow causal testing of genes involved in ferrous iron binding. RNA-seq and proteomics can reveal downstream pathways affected by Fe(II) dysregulation. Clinical trials provide evidence for nutritional and therapeutic interventions targeting iron status.
How CRISPR Can Be Used to Study GO:0008198 ferrous iron binding
Knockout
CRISPR knockout of genes encoding Fe(II)-binding proteins, such as DMT1, can reveal their requirement for iron uptake and systemic iron homeostasis. Knockout models are also used to test whether a candidate gene is essential for ferroptosis protection.
Point Mutation
Point mutations in Fe(II)-coordinating residues can dissect the contribution of individual ligands to binding affinity and function. For example, mutating ferritin residues involved in Fe(II) oxidation can separate binding from catalytic activity.
Knock-in
Knock-in of tagged or disease-associated variants allows tracking of Fe(II)-binding proteins in vivo and testing of patient-specific mutations. This approach is valuable for validating variants identified in iron-related disorders.
Overexpression
Overexpression of Fe(II)-binding proteins such as lactoferrin or ferritin can test protective effects against iron overload or anemia. Overexpression models are also used to study bacterial iron acquisition proteins like FpvC.
How EDITGENE Supports ferrous iron binding Research
Researchers studying ferrous iron binding-related genes often need to determine whether a candidate gene is causally involved in iron transport, storage, or ferroptosis. EDITGENE provides CRISPR-based cell models and screening services to accelerate this causal validation.
Contact EDITGENE today to design your custom CRISPR model for ferrous iron binding research.
Frequently Asked Questions About ferrous iron binding
What is GO:0008198 ferrous iron binding?
GO:0008198 is a Gene Ontology molecular function term defined as binding to a ferrous iron ion, Fe(II).
What genes are involved in ferrous iron binding?
Key genes include DMT1, ferritin, FpvC, lactoferrin, and hepcidin, among others.
How is ferrous iron binding studied?
It is studied using ITC, Mössbauer spectroscopy, crystallography, ferroptosis assays, and CRISPR models.
Why is ferrous iron binding important in anemia?
Ferrous iron binding enables iron absorption and delivery for hemoglobin synthesis, and its disruption causes iron-deficiency anemia.
What is the difference between ferrous and ferric iron binding?
Ferrous iron binding refers to Fe(II), while ferric iron binding refers to Fe(III); proteins can discriminate between these redox states.
Which proteins bind ferrous iron in bacteria?
FpvC from Pseudomonas aeruginosa is a well-characterized bacterial ferrous iron binding protein.
How does ferritin bind ferrous iron?
Ferritin binds Fe(II) and catalyzes its oxidation to Fe(III) for safe storage.
Can CRISPR be used to study ferrous iron binding?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are widely used to study Fe(II)-binding genes.
What diseases are linked to ferrous iron binding?
Iron-deficiency anemia, iron overload, ferroptosis, and bacterial infections are linked to ferrous iron binding.
What methods measure Fe(II) binding affinity?
Isothermal titration calorimetry and surface plasmon resonance are commonly used to measure Fe(II) binding affinity.
Conclusion
GO:0008198 ferrous iron binding is a fundamental molecular function that underpins iron absorption, transport, storage, and catalysis. Its dysregulation is implicated in anemia, iron overload, ferroptosis, and infection, making it a critical area of biomedical research. Advances in CRISPR modeling and biophysical methods continue to clarify how Fe(II)-binding proteins work and how they can be targeted therapeutically.
References
- 1. Powers JM et al.. 2017. Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia: A Randomized Clinical Trial.. JAMA 317(22):2297-2304 PMID: 28609534
- 2. Zhu X et al.. 2024. Cold-inducible RNA binding protein alleviates iron overload-induced neural ferroptosis under perinatal hypoxia insult.. Cell Death Differ 31(4):524-539 PMID: 38388728
- 3. El Amrousy D et al.. 2022. Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial.. Pediatr Res 92(3):762-766 PMID: 35681097
- 4. Vigouroux A et al.. 2020. A unique ferrous iron binding mode is associated with large conformational changes for the transport protein FpvC of Pseudomonas aeruginosa.. FEBS J 287(2):295-309 PMID: 31318478
- 5. Pfaffen S et al.. 2013. Mechanism of ferrous iron binding and oxidation by ferritin from a pennate diatom.. J Biol Chem 288(21):14917-25 PMID: 23548912
- 6. Conrad ME et al.. 2000. Iron absorption and transport-an update.. Am J Hematol 64(4):287-98 PMID: 10911382
- 7. Yanatori I et al.. 2019. DMT1 and iron transport.. Free Radic Biol Med 133:55-63 PMID: 30055235
- 8. Fuqua BK et al.. 2012. Intestinal iron absorption.. J Trace Elem Med Biol 26(2-3):115-9 PMID: 22575541
